Company Overview of Cantex Pharmaceuticals, Inc.
Cantex Pharmaceuticals, Inc., a biotechnology company, engages in developing cancer treatments. It offers ODSH, a low anticoagulant heparin derivative that reduces the incidence, severity, and duration of reduction of platelet counts caused by chemotherapy. The company also provides Disulfiram-Copper Chelate that includes non-overlapping cancer stem cell killing mechanisms of actions, including proteasome inhibition, induction of reactive oxygen species, and strong inhibition of ALDH and the NF Kappa B pathways for metastatic breast cancer, pancreatic cancer, and glioblastoma. Cantex Pharmaceuticals, Inc. was formerly known as PARINGENIX INC. The company was incorporated in 2002 and is based...
1792 Bell Tower Lane
Weston, FL 33326
Founded in 2002
Key Executives for Cantex Pharmaceuticals, Inc.
Chairman of The Board and Chief Executive Officer
Compensation as of Fiscal Year 2014.
Cantex Pharmaceuticals, Inc. Key Developments
Cantex Pharmaceuticals, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-14-2015 10:40 AM
Apr 6 15
Cantex Pharmaceuticals, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-14-2015 10:40 AM. Venue: Westin Grand Central Hotel, New York, New York, United States.
Cantex Pharmaceuticals, Inc. Presents at BioFlorida Annual Conference, Oct-14-2014 11:15 AM
Oct 11 14
Cantex Pharmaceuticals, Inc. Presents at BioFlorida Annual Conference, Oct-14-2014 11:15 AM. Venue: Harbor Beach Marriott, Ft. Lauderdale, Florida, United States. Speakers: Stephen Marcus, President and Director.
ParinGenix, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013
Oct 4 13
ParinGenix, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013 . Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|